Literature DB >> 27622614

The role of outpatient visit after operative treatment of ankle fractures.

Mikko T Ovaska1, Timo Nuutinen2, Rami Madanat2, Tatu J Mäkinen2, Tim Söderlund2.   

Abstract

It is a common practice that patients have a scheduled follow-up visit with radiographs following ankle fracture surgery. The aim of this study was to evaluate whether an early outpatient visit (<3 weeks) after ankle fracture surgery resulted in a change in patient management. For this study, 878 consecutive operatively treated ankle fracture patients with an early outpatient clinical-radiological visit were reviewed. The outcome measure was a change in treatment plan defined as any procedure, medication, or surgical intervention that is not typically implemented during the uncomplicated healing process of an acute fracture. A change in treatment plan was observed in 9.8% of operatively treated ankle fracture patients. The mean age of the patients was 48 years and the mean follow-up time was 64 months. Of the changes in treatment plan, 91% were exclusively due to clinical findings such as infection. Only three of 878 patients required a change in their treatment plan based merely on the findings of the radiographs taken at the outpatient visit. Only 37% of the patients requiring a change in their postoperative management had solicited an unanticipated visit before the scheduled outpatient visit due to clinical problems such as infection or a cast-related issue. Our study showed that every tenth operatively treated ankle fracture patient requires a change in their treatment plan due to a clinical problem such as infection or a cast-related issue. Although at hospital discharge all patients are provided with written instructions on where to contact if problems related to the operated ankle emerge, only one third of the patients are aware of the clinically alarming symptoms and seek care when problems present. Our findings do not support obtaining routine radiographs at the early outpatient visit in an ankle fracture patient without clinical signs of a complication.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Ankle fracture; Complication; Control visit; Infection; Radiograph

Mesh:

Year:  2016        PMID: 27622614     DOI: 10.1016/j.injury.2016.09.008

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  6 in total

1.  Patient injury claims involving fractures of the distal radius.

Authors:  Henrik Sandelin; Eero Waris; Eero Hirvensalo; Jarkko Vasenius; Heini Huhtala; Timo Raatikainen; Teemu Helkamaa
Journal:  Acta Orthop       Date:  2018-01-22       Impact factor: 3.717

2.  Foot and ankle service adaptation in response to COVID-19 and beyond.

Authors:  I Feeley; T McAleese; K Clesham; D Moloney; G Crozier-Shaw; A Hughes; T Bayer
Journal:  Ann Med Surg (Lond)       Date:  2020-04-28

3.  Routine radiographic follow-up is not necessary after physeal fractures of the distal tibia in children.

Authors:  Antti Stenroos; Jussi Kosola; Jani Puhakka; Topi Laaksonen; Matti Ahonen; Yrjänä Nietosvaara
Journal:  Acta Orthop       Date:  2019-07-22       Impact factor: 3.717

4.  Minimizing Nonessential Follow-up for Hip Fracture Patients.

Authors:  Michael S Reich; Julie A Switzer; Andrew Sibley; Lisa K Schroder; Sandy Vang; Mai P Nguyen
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-06-02

5.  The value of radiography in the follow-up of extremity fractures: a systematic review.

Authors:  P van Gerven; S M Rubinstein; C Nederpelt; M F Termaat; P Krijnen; M W van Tulder; I B Schipper
Journal:  Arch Orthop Trauma Surg       Date:  2018-08-14       Impact factor: 3.067

6.  Reduction of routine use of radiography in patients with ankle fractures leads to lower costs and has no impact on clinical outcome: an economic evaluation.

Authors:  P van Gerven; J M van Dongen; S M Rubinstein; M F Termaat; M El Moumni; W P Zuidema; P Krijnen; I B Schipper; M W van Tulder
Journal:  BMC Health Serv Res       Date:  2020-09-22       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.